The study's result focused on specific outcomes, particularly the association between the Ki-67 index, Ki positive count of individuals, tumor size measurement by MRI, and predictive radiomic-clinicopathological models in predicting pCR following NAC in breast cancer. This evidence concerns the gene MKI67 and breast cancer.